Characterization of Acquired Receptor Tyrosine Kinase Fusions as Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors

被引：0

作者：

Xu, H. ^{[1
]}

Shu, Y. ^{[1
]}

Jian, H. ^{[2
]}

Shen, J. ^{[3
]}

Xiang, J. ^{[4
]}

Li, H. ^{[4
]}

Li, B. ^{[5
]}

Zhang, T. ^{[4
]}

Zhang, L. ^{[4
]}

Mao, X. ^{[4
]}

机构：

[1] Nanjing Med Univ, Affiliated Hosp 1, Oncol, Nanjing, Jiangsu, Peoples R China

[2] Shanghai Jiao Tong Univ, Oncol, Shanghai Chest Hosp, Shanghai, Peoples R China

[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Emergency, Shanghai, Peoples R China

[4] Burning Rock Biotech, Dept Med, Guangzhou, Guangdong, Peoples R China

[5] Burning Rock Biotech, Bioinformat Dept, Guangzhou, Guangdong, Peoples R China

来源：

关键词：

EGFR-TKI; fusion; acquired drug resistance;

D O I：

10.1016/j.jtho.2019.08.1175

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.14-24

引用

页码：S562 / S563

页数：2